Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
《公司業績》華領醫藥全年虧損擴至2.11億人民幣
2024-03-31T  
華領醫藥(02552.HK)第二代GKA向FDA提交新藥臨床試驗申請
2023-12-21T  
華領醫藥(02552.HK)新藥華堂寧獲納入國家醫保藥品目錄
2023-12-14T  
華領醫藥已收到拜耳8億人民幣里程碑付款
2023-11-23T  
華領醫藥-B續吐21%成交增 中期續蝕9,010萬人幣
2023-08-25T  
《公司業績》華領醫藥中期虧損收窄至9,010萬人民幣
2023-08-25T  
華領醫藥藥物確認實現重要里程碑 有權收取8億人幣里程碑付款
2023-08-21T  
醫藥股普遍造好跑贏大市 百濟神州、康方生物及信達生物續升9.5%-11% 惟雲頂新耀回吐14%
2023-07-04T  
醫藥股普遍造好 康希諾、啟明、醫渡及華領急升11%-16%
2023-06-26T  
「B仔股」普遍跑贏大市 康寧傑瑞、基石藥業及微創機械人漲9%-13%
2023-06-16T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.